TY -的T1 - 1年随访神经症状与postacute non-hospitalized神经科门诊病人后遗症的COVID-19 (PASC) (S49.首页009) JF -神经学乔-神经学做- 10.1212 / WNL。0000000000204277六世- 100 - 17补充2 SP - 4874 AU -苏Thawani盟——雪莉Fung盟瑞秋肯尼AU -萨拉·海曼盟Samarah Ahmed AU -阿齐兹Seixas盟Girardin jean - louis AU -珍妮弗Frontera盟-史蒂文Galetta盟-劳拉Balcer Y1 - 2023/04/25 UR - //www.ez-admanager.com/content/100/17_Supplement_2/4874.abstract N2 -目的:我们神经症状的进化特征,自我感觉恢复non-h首页ospitalized参与者在最初基线评估急性后遗症的COVID-19 (PASC)。背景:在一些患者神经症状持续COVID-19感染。设计/方法:在后续的研究中一个基线群SARS-CoV-2 laboratory-positive病人评估PASC(2020年11月- 2021年8月),49.5%(46/93)参与者完成随访电话问卷调查对他们的神经symptomsResults:最初的PASC评估后平均年龄为51.1岁(SD = 16.5), 63%(29/46)是女性和95%收到COVID-19接种疫苗。最初的PASC评估发生在中位数为9.5个月(IQR = 8.0 - -11.9) COVID-19后感染。第一次访问之间的时间,1年的随访中是15.4个月(IQR = 14.5 - -16.1)。症状出现和1年期后续访问之间的平均时间为25.8个月(IQR = 23.0 - -17.4)。最常见症状随访报道包括词找到困难(63%),改变在内存中(59%),焦虑(56%)、疲劳(54%),和眼睛的自治特性(54%)。最初报告的五大症状/基线的访问中,疲劳,词发现困难,改变记忆,和失眠没有显著不同的1年随访,和气短明显减少(51 vs 30%, p = 0.04, McNemer的测试)。自主眼睛症状显著增加(31 vs 54%, p = 0.03)而出现头痛(44 vs 44%, p = 1.00),头晕的报道(48 vs 43%, p = 1.00),心悸(24 vs 33%, p = 0.15),和嗅觉缺失症并没有改变从基线到后续(p = 0.44),但嗅觉缺失改善从急性感染1年随访(35% vs 70, p = 0.0006)。结论:Non-hospitalized神经科门诊PASC继续首页体验,疲劳,词发现困难,改变内存和头痛。更多的参与者在随访报道自主眼睛症状表明筛查神经异常和vision-related症状可能是重要的在这个人口在诊所。披露:Thawani博士没有披露。 Ms. Fung has nothing to disclose. Rachel Kenney has nothing to disclose. Ms. Hyman has nothing to disclose. Ms. Ahmed has nothing to disclose. Azizi Seixas has nothing to disclose. Girardin Jean-Louis has nothing to disclose. Dr. Frontera has received personal compensation in the range of $500-$4,999 for serving as a Consultant for FirstKindMedical. Dr. Frontera has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Physician Education Resource. The institution of Dr. Frontera has received research support from NIH. The institution of Dr. Frontera has received research support from Alexion. Dr. Frontera has received publishing royalties from a publication relating to health care. Dr. Galetta has nothing to disclose. An immediate family member of Dr. Balcer has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Children’s Hospital of Philadelphia. Dr. Balcer has received personal compensation in the range of $50,000-$99,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for North American Neuro-Ophthalmology Society. ER -